$Hang Seng Index(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$REMEGEN-B(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $CLOVER BIO-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$維亜生物科技(01873.HK)$...
$開拓薬業(09939.HK)$ With the opening up, it is inevitable the Covid cases will jump into hundreds of thousand. This is where this covid treatment drug will greatly benefit along with some of the other approved Covid treatments
The latest US effort to reduce reliance on China is striking hard at the Asian nation’s biotech stocks, as investors price in more indications of decoupling between the world’s two biggest economies. Following US President Joe Biden’s executive order to bolster domestic bio-manufacturing and cut reliance on foreign companies, bellwether Chinese stocks such as$薬明生物(02269.HK)$Wuxi Biologics Cayman Inc. and$無錫薬明康徳(02359.HK)$WuXi AppT...
5
1
報告
Mao MM :
How much are the Chinese biotech dependent on US market as their final export destination?
Hang Seng pharmaceuticals sector slumps more than 6%, Kintor Pharma falls 20%, Fosun Pharma down 16% as investors cheer Merck's antiviral pill. $医薬品(BK1067.HK)$ $復星国際(00656.HK)$ $開拓薬業(09939.HK)$
$康寧傑瑞(09966.HK)$$開拓薬業(09939.HK)$$信達生物製薬(01801.HK)$Today Hong Kong pharmaceutical and biotech stocks fell 2.36%, industry groups in Hong Kong or top 5, kill the biological medicine market valuation, capital is still wary of innovative drug, exploit medicine, corning jerry that is called a fall, but has strong industry leading cinda biology, growth of 4.16% in the pharmaceutical sector in the first, Market money still likes and likes a few big champions.
開拓薬業に関するコメント
HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off
Pharmaceuticals were sold off. $REMEGEN-B(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亜生物科技(01873.HK)$ ...
With the opening up, it is inevitable the Covid cases will jump into hundreds of thousand. This is where this covid treatment drug will greatly benefit along with some of the other approved Covid treatments
US efforts to boost biotech industry lead to China selloff
Following US President Joe Biden’s executive order to bolster domestic bio-manufacturing and cut reliance on foreign companies, bellwether Chinese stocks such as $薬明生物(02269.HK)$ Wuxi Biologics Cayman Inc. and $無錫薬明康徳(02359.HK)$ WuXi AppT...
Kintor soared on news of Covid-19 drug efficacy.
$医薬品(BK1067.HK)$
$復星国際(00656.HK)$
$開拓薬業(09939.HK)$
まだコメントはありません